WASHINGTON (AP) — House lawmakers have issued a subpoena to compel former Turing Pharmaceuticals CEO Martin Shkreli, reviled for price-gouging, to appear at a congressional hearing next Tuesday.
The House Committee on Oversight and Government Reform is investigating several companies for exorbitant drug price increases, including embattled Canadian drugmaker Valeant Pharmaceuticals.
Shkreli became notorious after his company Turing hiked the price of Daraprim, the only approved drug for a rare and sometimes deadly parasitic infection, by 5,000 percent. Since then, Shkreli has been deluged with criticism from patients, politicians and the media, with some labeling him the “most hated man in America.”
Last month, the 32-year-old former hedge fund manager was arrested in New York and charged with securities fraud and conspiracy related to another pharmaceutical company he previously ran called Retrophin. Shkreli was released on $5 million bail and said he had resigned as CEO of Turing, which he founded and ran.
Shkreli could not immediately be reached for comment Wednesday evening.
The House committee issued the demand January 11, according to a copy obtained by the Associated Press on Wednesday. They are also seeking testimony from Turing’s chief commercial officer, Nancy Retzlaff, Valeant Pharmaceutical’s interim CEO, Howard Schiller, and experts from government and the private sector.
Concerns about sky-high drug prices have been building for years but boiled over last fall after news reports about Turing, Valeant and a handful of other drugmakers hiking prices of old drugs many times over their prior cost.
Valeant drew Congress’ interest following its purchase of the life-saving heart drugs Nitropress and Isuprel. The company, known for gobbling up smaller drugmakers to get their products and then slashing jobs and research programs, jacked up the drugs’ prices shortly after buying them from Marathon Pharmaceuticals in February, tripling one and raising the other six-fold.
Daraprim, which Turing acquired in August, is the only approved drug for a life-threatening parasitic infection that mainly strikes pregnant women, cancer patients and AIDS patients.
Amid mounting criticism from patients, doctors and politicians, Shkreli pledged to lower Daraprim’s price, but later reneged and instead offered hospitals a 50 percent discount — still amounting to a 2,500 percent increase. Patients normally take most of the weeklong treatment at home, so they still face the 5,000 percent price increase, though Turing is offering financial aid to those who can’t afford the drug.
Both Turing and Valeant have also received multiple subpoenas from federal prosecutors seeking information about drug pricing and other business practices.
Copyright 2016 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Republicans will start by apologizing for Shkreli’s mistreatment, or did he not donate enough to them (see also: BP, Joe Barton ®)?
Worse. He tried to donate to Bernie Sanders (who refused his money). This guy has no friends up on the hill.
Last October, a California drug compounding company offered a cheaper version of Daraprim. A bottle of 100 tablets sells for $99.00. That’s Ninety nine cents a pill. Link:
What a waste of time. Because he’s already under indictment he’ll just sit there and repeatedly invoke the Fifth.
So how about they do something useful, like pass legislation allowing Medicare to negotiate drug prices. If they just want a bogeyman they could save taxpayers a fortune and simply look in the mirror.
Medicare pays doctors and hospitals a set amount for a particular procedure or diagnosis. They need to do the same for prescription medications to prevent this sort of outrage, with maybe a carve out for truly unique, one of type drugs.